Senetek PLC Announces Collaboration With Allure Cosmetics; Companies to Develop and Market New Kinetin Products
NAPA, Calif., Nov. 27 /PRNewswire/ -- Senetek PLC (Nasdaq: SNTKY - news), www.senetekplc.com , today announced that it has entered into a collaboration with Allure Cosmetics to market Kinetin to Allure's corporate client base in the direct response, salon-esthetician, spa and natural products markets.
The two companies also agreed to develop new Kinetin products. Allure Cosmetics is a privately held manufacturing and marketing company that in addition to manufacturing products for corporate clients, sells innovative skin care products nationwide. Skin Therapy, the company's leading skin care line, incorporates Kinetin (N6 Furfuryladenine) in KQ10 Serum and Cream products. Two additional products, KQ10 Eye Firm and KQ10 Decollete Cream, are scheduled to be introduced by year-end.
``The collaboration allows Senetek and Allure to jointly market Kinetin to Allure Cosmetics' existing customer base,'' stated Frank J. Massino, Senetek Chairman and CEO. ``Allure Cosmetics has established successful relationships in these markets and we are very pleased for this opportunity to work together to develop and market new Kinetin-based products.''
Sam Dhatt, President and CEO, Allure Cosmetics, said, ``Based on my long-term industry experience, we're especially pleased to be marketing products made with Kinetin due to Kinetin's outstanding performance and acceptability in the marketplace. We are well known for our ability to research and utilize ingredients that provide cutting edge technology to skin care products.''
Senetek's patented skincare ingredient Kinetin (N6-furfuryladenine) is an essential plant growth factor that retards senescence of plants and delays age-related changes in cultured human skin cells. Kinetin products have been successfully tested at the Department of Dermatology, University of California, Irvine, showing good-to-excellent results in reversing the signs of photodamaged skin, and promoting the appearance of healthy looking skin. In clinical trials, Kinetin products demonstrated improvement in the reduction of fine lines and wrinkles and mottled hyperpigmentation without the irritation and photosensitivity associated with the use of retinoids and alpha-hydroxy acids.
Allure Cosmetics, Hayward, California, was founded in 1995 by Sam Dhatt, who holds an MBA in Finance and Marketing and has more than 20 years industry experience specializing in chemistry. The company recently purchased a new 51,000 square ft. manufacturing and R&D facility. The mission of Allure Cosmetics is to provide innovative products of the highest quality.
Senetek PLC, headquartered in Napa, California, is a science driven biopharmaceutical company engaged in the development of skincare/dermatological and sexual dysfunction products. Kinetin, the Company's patented anti-aging skincare technology, has been licensed to leading cosmetic and dermatological companies worldwide. Invicorp(TM) is Senetek's technology for the treatment of Erectile Dysfunction, a condition suffered by more than 100 million men worldwide. To learn more about Senetek, visit the Company's Website at senetekplc.com .
Visit SENETEK PLC's Website at senetekplc.com
Safe Harbor Statement
This news release may contain statements that may be considered ``forward looking statements'' under the Federal securities laws, including statements concerning the revenue and licensing income we may receive in the future under licenses of our products, and the additional licensing agreements we may enter into during 2001. No forward-looking statement we make is a guarantee of future performance or events. Actual results or events may differ materially from those in the forward-looking statements as a result of various factors, including the risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2000 filed with the Securities and Exchange Commission.
SOURCE: Senetek PLC |
